Comparison of the healthcare-associated infections in intensive care units in Turkey before and during COVID-19.

IF 1 Q3 MEDICINE, GENERAL & INTERNAL The Egyptian Journal of Internal Medicine Pub Date : 2023-01-01 DOI:10.1186/s43162-023-00215-2
Sema Sarı, Ferhat Arslan, Sema Turan, Tuğçe Mengi, Handan Ankaralı, Ahmet Sarı, Mine Altınkaya Çavuş, Çilem Bayındır Dicle, Derya Tatlısuluoğlu, Hüseyin Arıcan, Yahya Tahta, Haluk Vahaboğlu
{"title":"Comparison of the healthcare-associated infections in intensive care units in Turkey before and during COVID-19.","authors":"Sema Sarı,&nbsp;Ferhat Arslan,&nbsp;Sema Turan,&nbsp;Tuğçe Mengi,&nbsp;Handan Ankaralı,&nbsp;Ahmet Sarı,&nbsp;Mine Altınkaya Çavuş,&nbsp;Çilem Bayındır Dicle,&nbsp;Derya Tatlısuluoğlu,&nbsp;Hüseyin Arıcan,&nbsp;Yahya Tahta,&nbsp;Haluk Vahaboğlu","doi":"10.1186/s43162-023-00215-2","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Secondary bacterial infections are an important cause of mortality in patients with coronavirus disease 2019 (COVID-19). All healthcare providers acted with utmost care with the reflex of protecting themselves during the COVID-19 period. We aimed to compare the rates of ventilator-associated pneumonia (VAP) and bloodstream infections (BSIs) in our intensive care units (ICUs) before and during the COVID-19 outbreak surges.</p><p><strong>Methods: </strong>This multicenter, retrospective, cross-sectional study was performed in six centers in Turkey. We collected the patient demographic characteristics, comorbidities, reasons for ICU admission, mortality and morbidity scores at ICU admission, and laboratory test data.</p><p><strong>Results: </strong>A total of 558 patients who required intensive care from six centers were included in the study. Four hundred twenty-two of these patients (males (62%), whose mean age was 70 [IQR, 58-79] years) were followed up in the COVID period, and 136 (males (57%), whose mean age was 73 [IQR, 61-82] years) were followed up in the pre-COVID period. BSI and VAP rates were 20.7 (19 events in 916 patient days) and 17 (74 events in 4361 patient days) with a -3.8 difference (<i>P</i> = 0.463), and 33.7 (31 events in 919 patient days) and 34.6 (93 events in 2685 patient days) with a 0.9 difference (<i>P</i> = 0.897), respectively. The mortality rates were 71 (52%) in pre-COVID and 291 (69%) in COVID periods.</p><p><strong>Conclusion: </strong>Protective measures that prioritize healthcare workers rather than patients and exceed standard measures made no difference in terms of reducing mortality.</p>","PeriodicalId":22465,"journal":{"name":"The Egyptian Journal of Internal Medicine","volume":"35 1","pages":"30"},"PeriodicalIF":1.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108807/pdf/","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Egyptian Journal of Internal Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s43162-023-00215-2","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 1

Abstract

Background: Secondary bacterial infections are an important cause of mortality in patients with coronavirus disease 2019 (COVID-19). All healthcare providers acted with utmost care with the reflex of protecting themselves during the COVID-19 period. We aimed to compare the rates of ventilator-associated pneumonia (VAP) and bloodstream infections (BSIs) in our intensive care units (ICUs) before and during the COVID-19 outbreak surges.

Methods: This multicenter, retrospective, cross-sectional study was performed in six centers in Turkey. We collected the patient demographic characteristics, comorbidities, reasons for ICU admission, mortality and morbidity scores at ICU admission, and laboratory test data.

Results: A total of 558 patients who required intensive care from six centers were included in the study. Four hundred twenty-two of these patients (males (62%), whose mean age was 70 [IQR, 58-79] years) were followed up in the COVID period, and 136 (males (57%), whose mean age was 73 [IQR, 61-82] years) were followed up in the pre-COVID period. BSI and VAP rates were 20.7 (19 events in 916 patient days) and 17 (74 events in 4361 patient days) with a -3.8 difference (P = 0.463), and 33.7 (31 events in 919 patient days) and 34.6 (93 events in 2685 patient days) with a 0.9 difference (P = 0.897), respectively. The mortality rates were 71 (52%) in pre-COVID and 291 (69%) in COVID periods.

Conclusion: Protective measures that prioritize healthcare workers rather than patients and exceed standard measures made no difference in terms of reducing mortality.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
2019冠状病毒病之前和期间土耳其重症监护病房医疗保健相关感染的比较
背景:继发性细菌感染是2019冠状病毒病(COVID-19)患者死亡的重要原因。在COVID-19期间,所有医疗保健提供者都极为谨慎地采取了保护自己的措施。我们的目的是比较在COVID-19爆发激增之前和期间重症监护病房(icu)呼吸机相关肺炎(VAP)和血液感染(bsi)的发生率。方法:这项多中心、回顾性、横断面研究在土耳其的6个中心进行。我们收集了患者的人口学特征、合并症、入住ICU的原因、入住ICU时的死亡率和发病率评分以及实验室检测数据。结果:共有来自6个中心的558名需要重症监护的患者被纳入研究。其中422例(男性,占62%,平均年龄70 [IQR, 58 ~ 79]岁)在新冠肺炎期间随访;136例(男性,占57%,平均年龄73 [IQR, 61 ~ 82]岁)在新冠肺炎前随访。BSI和VAP发生率分别为20.7(916患者日19例)和17(4361患者日74例),差异为-3.8 (P = 0.463); BSI和VAP发生率分别为33.7(919患者日31例)和34.6(2685患者日93例),差异为0.9 (P = 0.897)。新冠肺炎前期死亡率为71例(52%),新冠肺炎期间死亡率为291例(69%)。结论:优先考虑医护人员而不是患者的防护措施和超出标准的防护措施在降低死亡率方面没有差异。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
81
审稿时长
9 weeks
期刊最新文献
Predictors of COVID-19 outcome in type 2 diabetes mellitus: a hospital-based study Platelet to lymphocyte ratio: can it be an early economical mortality predictor of AKI patients? Correlation between neutrophil to lymphocyte ratio and platelet to lymphocyte ratio with proteinuria in different stages of chronic kidney disease Sinus arrest associated with diabetic ketoacidosis regressing to sinus rhythm after compensation of diabetic process: a case report and review of literature The multidimensional benefits of eicosapentaenoic acid: from heart health to inflammatory control
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1